Los Angeles +

Elise Culliton represents clients across the health care industry in matters relating to regulatory compliance and complex business transactions.

Elise's practice is focused on representing hospitals, health systems, academic medical centers, digital health companies, pharmaceutical companies, and various other health care and life sciences companies in implementing innovative integration and alignment strategies. She assists clients with acquisitions, affiliations, joint ventures, joint operating arrangements, corporate reorganizations, and asset and stock purchases and supports clients in assessing and mitigating regulatory risks related to such transactions. She also assists client with assessing strategies for hospital closure or service line reductions and the acquisition of distressed hospital assets.

Elise also provides analysis regarding regulatory issues and compliance strategies, with an emphasis on pricing and reimbursement considerations, the Medicaid Drug Rebate Program, the 340B Program, graduate medical education programs, provider-based status and site-neutral reimbursement, licensing, and Medicare conditions of participation. She assists providers in operational and administrative responses to Centers for Medicare & Medicaid Services' survey and deficiency findings, including immediate jeopardy situations, and program integrity functions, including payment suspensions. Elise also advises clients on repayments and remediation strategies to private payors and state and federal agencies, including the Medicare and Medicaid program.

She is a member of the American Health Lawyers Association and the California Society for Healthcare Attorneys.


  • Ascension enters into strategic laboratory collaboration with LabcorpJones Day advised Ascension with respect to its strategic alliance with Labcorp whereby Labcorp will manage Ascension’s hospital-based laboratories in 10 states and purchase the assets of the health system’s outreach laboratory business.
  • City of Hope acquires Cancer Treatment Centers of AmericaJones Day advised City of Hope, a world-renowned, National Cancer Institute (NCI)-designated comprehensive cancer research and treatment organization, in connection with its acquisition of Cancer Treatment Centers of America, a network of oncology hospitals and outpatient care centers across the United States.
  • Private equity-backed post-acute care organization forms CINJones Day assisted a for-profit, private equity-backed company in creating an innovative post-acute care clinically integrated network in the southwestern U.S.
  • Digital health companies, specialty hospitals, and health systems maintain compliance with multistate requirements through 50-state surveyJones Day is representing digital health companies, specialty hospitals, and health systems in maintaining compliance with multistate requirements through a regularly updated, extensive 50-state survey on state laws and regulations applicable to telehealth activities of physicians and other health care professionals including licensing, establishing patient relationships, provider-to-provider consulting, supervision and delegation among providers, and prescribing and treatment standards.